November 2015
Where are companies best advised to obtain their clinical data, the EU or the US and why?
June 2015
What the FDA wants you to know when conducting PMA clinical trials outside of the United States
January 2012
Regulatory Challenges in Getting Total Disc Replacements Onto the Market in an Era of Increased Food and Drug Administration Scrutiny
November 2011
Coverage of IDE Clinical Trial Costs: Navigating the Medicare Maze
June 2011
A Historical Framework for Accountable Care Organizations: Will CMS Meet Its Long-Term Goals with this Initiative?
July 2010
Tools, Tips and solutions for coding and billing community.
May 2010 
Device firms with well-planned reimbursement strategies position themselves to secure market share and sales they might otherwise have lost.
March 2009 
The year 2009 signals change within the U.S. healthcare framework—from the inauguration of the 44th president, Barack Obama, to sweeping changes in Congress. 
May/June 2009
How Medicare Rule Would Impact Orthopedic Technology Firms 
November 2008
Comparative effectiveness research examines clinical outcomes, or the clinical effectiveness, of alternative therapies for the same condition.
September/October 2008
The Centers for Medicare and Medicaid Services (CMS) recently released several proposed and final rules outlining
July 2008
Completing a pivotal trial may be the biggest challenge developers of artificial discs face as the market for the devices gets more crowded, say consultants
July 2008
Pending patent litigation between Medtronic and Spine Solutions could shape the artificial disc
May 2008
In recent years, the issue of medical technology reimbursement has moved from passive discussion to the
Spring 2008
Data needed for a successful regulatory approval does not necessarily encompass the data needed for successful
Non-fusion spinal implant maker Paradigm Spine decided t o spend 15%-20% more than needed to satisfy FDA's data
Volume 62,
Number 3, 2007
Food and drug law journal. Analyzing the Laws, Regulations, and Policies Affecting FDA-Regulated Products
FDA Ortho Panel Recommends STAR Ankle PMA Approval— With Elephant in the Room
An independent panel of reviewers voted unanimously Tuesday to recommend that federal medical regulators approve the first artificial replacement for failing disks in
MCRA is not a law firm and neither provides legal advice to its clients nor can affirm the legal or regulatory validity of the materials of which it provides. MCRA recommends that its clients consult an attorney to discuss any legal issues that relate to its business and/or MCRA services